NIH continues to update funding opportunity announcements (FOAs) to prepare for the transition to FORMS-E and accommodate policy changes affecting applications with due dates on or after January 25, 2018.
As part of the updates, NIH is issuing (or reissuing) FOAs with titles that specify whether clinical trials are (CTs) optional, required, or not allowed.
Here are a few examples:
- Zika Virus (ZIKV) Complications (R21, Clinical Trial Optional)
- NIH Exploratory/Developmental Research Grant Program (Parent R21, Clinical Trial Required)
- Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Not Allowed)
- Mentored Research Scientist Development Award (Parent K01, Independent Clinical Trial Not Allowed)
If you’re planning to submit an application with a due date during the transition period from FORMS-D to FORMS-E, be sure that you are:
- Using the correct FORMS set. In some cases, a FOA has been reissued with FORMS-E but the previoius FOA that uses FORMS-D is still active for due dates before January 25, 2018. To help you decide whether to use FORMS-D or the new FORMS-E, see our previous articles:
- “Take Note of Special Cases for Transition Dates to FORMS-E” (September 6, 2017)
- “Available Now: Application Guides for FORMS-E” (October 18, 2017)
- Applying to a FOA with the correct CT designation. For due dates on or after January 25, 2018, should your research involve a CT, you must submit an application in response to a CT-specific FOA, as mandated in the NIH Policy on Funding Opportunity Announcements (FOA) for Clinical Trials.
- Applying to a FOA in which NIAID participates (if you want the application to be assigned to NIAID). For example, NIAID participates in the Mentored Patient-Oriented Research Career Development Award (Parent K23) FOA and the newly reissued Mentored Patient-Oriented Research Career Development Award (Parent K23, Independent Clinical Trial Not Allowed) FOA but not in the Mentored Patient-Oriented Research Career Development Award (Parent K23, Independent Clinical Trial Required) FOA.